Nonresponse to 17-alpha hydroxyprogesterone caproate for recurrent spontaneous preterm birth prevention: clinical prediction and generation of a risk scoring system.
Manuck, Tracy A. MD a,b,*; Stoddard, Gregory J. MS c; Fry, Rebecca C. PhD d; Esplin, Sean M. MD b,e; Varner, Michael W. MD b,e
[Article] American Journal of Obstetrics & Gynecology. 215(5):622e1-622e8, November 2016.

(Format: HTML, PDF)